Cloning refers not to a single procedure but to a family of techniques that share one goal: producing genetically identical copies of a biological entity, whether that entity is a short stretch of DNA, a single cell, or an entire organism. The method that captured public imagination was the birth of Dolly the sheep in 1996, but the molecular version of cloning, copying and amplifying a specific gene, has been routine in labs for decades. Understanding the distinctions between these techniques matters, because each serves different purposes, faces different obstacles, and raises different questions.
Gene Cloning and Modern DNA Assembly
The oldest and most widespread form of cloning happens at the molecular level. Researchers isolate a piece of DNA they are interested in, cut it with specific enzymes, and paste it into a small circular DNA carrier called a vector. That vector is slipped into bacterial cells, which then copy it every time they divide. The whole workflow moves through amplification, cutting, joining, transformation into bacteria, growing colonies, and screening to confirm the right fragment was captured.1PubMed. Classical Recombinant DNA Cloning This is the bread-and-butter method behind everything from producing insulin in bacteria to building the gene constructs used in more advanced cloning work.
Newer assembly methods have expanded what gene cloning can achieve. Golden Gate assembly, introduced in 2008, uses a special class of enzymes that cut DNA at sites away from where they bind, letting researchers stitch multiple fragments together seamlessly in one reaction. Gibson assembly takes a different approach, using an enzyme that chews back DNA ends so overlapping fragments can anneal and be sealed together, and it can handle fragments up to about 100 kilobases in length.2Heliyon. Recent advances in automated high-throughput oligonucleotide synthesis and DNA assembly These tools are the workhorses of synthetic biology, enabling researchers to build entire genetic pathways from scratch and insert them into organisms.
Somatic Cell Nuclear Transfer
When most people say “cloning,” they mean creating an organism that is a genetic copy of an existing adult. The technique behind this is somatic cell nuclear transfer, or SCNT. A researcher takes a body cell from the animal to be cloned, removes its nucleus, and transfers that nucleus into an egg cell whose own nucleus has been removed. The egg’s cellular machinery then attempts to reprogram the adult DNA back to an embryonic state, and if everything goes well, the resulting embryo can be implanted in a surrogate and carried to term.
Dolly the sheep, born in 1996, was the first mammal cloned from an adult body cell, and her creation had a massive impact on the field.3PubMed. The recent history of somatic cloning in mammals Before Dolly, many biologists believed that adult cells were too specialized to be wound back to an embryonic state. Her birth proved otherwise, but it also revealed just how difficult the process is. SCNT has remained inefficient across every species where it has been attempted, with high rates of failed pregnancies and fetal abnormalities, problems attributed to the somatic cell’s nucleus not being fully reset by the egg’s reprogramming machinery.4PubMed Central. Cloning animals by somatic cell nuclear transfer–biological factors
The Epigenetic Problem
The core difficulty with SCNT is epigenetic. When a cell specializes into, say, a skin cell or a muscle cell, chemical tags get attached to its DNA and the proteins that package it. These tags tell the cell which genes to keep active and which to silence. For SCNT to work, the egg cell must strip away essentially all of those tags and replace them with the pattern an embryo needs. This reprogramming is almost never complete.
Research has identified two major categories of epigenetic barriers. Before implantation, abnormal chemical marks on histone proteins, particularly a tag called H3K9me3, prevent genes from activating at the right moment during early embryo development. After implantation, a different problem emerges: the loss of another set of marks (H3K27me3) that normally maintain a pattern of gene activity inherited from each parent. When these marks are stripped away unevenly, the embryo loses its ability to regulate certain genes properly.5PubMed Central. Efficient Somatic Cell Nuclear Transfer by Overcoming Both Pre- and Post-Implantation Epigenetic Barriers Detailed genomic analyses of SCNT embryos have confirmed the complete loss of H3K27me3 imprinting, which likely explains many of the developmental defects seen after birth in cloned animals.6Cell Stem Cell. Overcoming Barriers to Somatic Cell Nuclear Transfer Reprogramming
Improving SCNT Efficiency
The field has pursued dozens of strategies to get around these epigenetic roadblocks. Broadly, these include tweaking the physical steps of the procedure itself and, more promisingly, using molecular tools to directly modify the chemical marks on the donor cell’s DNA before or after transfer.7PubMed Central. Strategies to Improve the Efficiency of Somatic Cell Nuclear Transfer
One breakthrough came from directly targeting the H3K9me3 barrier. Researchers found that injecting an enzyme called Kdm4d, which removes H3K9me3 marks, reactivated the majority of genes that were stuck silent in cloned embryos and dramatically improved success rates. Alternatively, using donor cells that had been genetically modified to lack the enzymes that place H3K9me3 marks in the first place produced similarly strong gains.8PubMed Central. Embryonic development following somatic cell nuclear transfer impeded by persisting histone methylation
This approach proved critical for one of the field’s biggest milestones: cloning primates. In 2018, researchers in China used Kdm4d mRNA injection combined with a drug called trichostatin A to successfully clone macaque monkeys from fetal fibroblasts. Roughly 45% of injected embryos reached the blastocyst stage, and a substantial fraction of those showed healthy inner cell masses comparable to normally fertilized embryos.9Cell. Cloning of Macaque Monkeys by Somatic Cell Nuclear Transfer The success demonstrated that the same epigenetic barriers operating in mice and livestock also limited primate cloning, and that the same molecular interventions could help overcome them.
Induced Pluripotent Stem Cells
A parallel approach to cellular reprogramming bypasses SCNT entirely. In 2006, Shinya Yamanaka’s lab showed that introducing just four genes, Oct3/4, Sox2, Klf4, and c-Myc, into ordinary mouse skin cells could rewind them into a state resembling embryonic stem cells.10Cell. Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors The following year, the same approach was demonstrated in human cells.11Cell. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors These induced pluripotent stem cells, or iPSCs, can theoretically be coaxed into becoming any cell type in the body, just as embryonic stem cells can.
The significance was enormous. iPSC technology offered a way to create patient-matched cells for research and therapy without needing donor eggs or creating embryos, sidestepping many of the ethical objections that had dogged therapeutic cloning.12PubMed Central. Molecular mechanisms of induced pluripotency It earned Yamanaka the Nobel Prize in 2012 and quickly became the dominant reprogramming method in labs worldwide.
Do iPSCs and SCNT Produce the Same Cells?
A lingering question in the field was whether cells derived from iPSCs are truly equivalent to those derived through SCNT. When researchers compared heart cells and blood-vessel cells grown from iPSCs against those grown from SCNT-derived embryonic stem cells using genetically matched (isogenic) lines, they found the two were functionally comparable in gene expression, cell behavior, and metabolism. Genome-wide analysis even suggested that iPSC-derived cells were more similar to their SCNT counterparts than to cells derived from standard IVF embryos, with the genetic background of the donor mattering more than which reprogramming method was used.13PubMed Central. Molecular and functional resemblance of differentiated cells derived from isogenic human iPSCs and SCNT-derived ESCs For most practical purposes in regenerative medicine, this has made iPSCs the more accessible route.
Therapeutic Cloning
Therapeutic cloning uses SCNT not to produce a new organism but to create embryonic stem cells that are a genetic match to a patient. The nucleus from a patient’s cell is transferred into a donor egg, the resulting embryo is grown to the blastocyst stage, and stem cells are harvested from it. Because these cells carry the patient’s own DNA, tissues grown from them should avoid immune rejection.14PubMed. Using therapeutic cloning to fight human disease: a conundrum or reality?
Animal studies have shown promising results for therapeutic cloning in the context of conditions like Parkinson’s disease, muscular dystrophy, and diabetes, and the technique also holds potential for growing entire organs from scratch.15PubMed Central. Therapeutic cloning: promises and issues In practice, though, the rise of iPSCs has diminished much of the urgency around therapeutic cloning. Most labs pursuing patient-matched cell therapies now work with iPSCs rather than SCNT, largely because iPSCs do not require donor eggs and avoid the controversy of creating and destroying embryos.
Health Problems in Cloned Animals
Even when cloned animals survive to birth, they face elevated health risks. The most well-documented is large offspring syndrome, a congenital overgrowth condition seen primarily in cloned cattle and sheep. Affected animals can weigh up to twice the normal birth weight and often present with organ enlargement, abdominal wall defects, and difficulty standing or nursing after birth.16PubMed. Large offspring syndrome in ruminants: current status and prediction during pregnancy The syndrome involves abnormalities in both the placenta and the fetus, and these problems can appear at different stages of pregnancy or after birth.17PubMed. Incidence of abnormal offspring from cloning and other assisted reproductive technologies
These issues trace back to incomplete epigenetic reprogramming. When the egg fails to fully erase and rebuild the donor cell’s gene-regulation marks, growth-controlling genes can become inappropriately active or silent, leading to the overgrowth phenotype. The good news is that cloned animals who survive infancy and pass through normal development often go on to live fairly normal lives, and their offspring, produced by natural breeding, do not typically show the same problems.
The Mitochondrial Wrinkle
A cloned animal is not a perfect genetic copy. The nucleus comes from the donor animal, but the mitochondria, tiny energy-producing structures with their own small genome, come mostly from the egg cell used in the procedure. This means the clone carries nuclear DNA from one animal and mitochondrial DNA from another.18Journal of Reproduction and Development. Functional consequences of mitochondrial mismatch in reconstituted embryos and offspring
To complicate things further, a small number of mitochondria from the donor cell can hitch a ride along with the transferred nucleus, creating a mix of two mitochondrial genomes within the same cell. This heteroplasmy can persist and even be passed to subsequent generations through the maternal line.19PubMed Central. Mitochondrial DNA transmission and confounding mitochondrial influences in cloned cattle and pigs Whether this mismatch causes real functional problems depends on how different the two mitochondrial genomes are. Within a species, the differences are usually minor enough to be tolerated. But in interspecies cloning, as we will see, the mismatch becomes a much bigger obstacle.
Telomere Resetting
One early fear about cloning was that cloned animals would be “born old,” carrying shortened telomeres inherited from their adult donor cells. Telomeres are protective caps on chromosome ends that shorten as a cell divides, and when they get too short, cells stop functioning properly. If a clone inherited the already-shortened telomeres of a six-year-old donor sheep, would it effectively start life with middle-aged chromosomes?
Research in cloned cattle delivered a reassuring answer. By the time SCNT embryos reached the blastocyst stage, telomerase, the enzyme that rebuilds telomeres, had already been reactivated. Cloned fetuses and newborns had telomere lengths comparable to naturally conceived animals of the same age, despite inheriting initially shorter telomeres from adult donor cells.20PubMed. Reprogramming of telomerase activity and rebuilding of telomere length in cloned cattle In some cases, cloned animals actually had telomeres longer than those of age-matched controls, suggesting the reprogramming process can overshoot.21PubMed. Extension of cell life-span and telomere length in animals cloned from senescent somatic cells Clones, it turned out, are not born old. Their cellular clocks get reset during development.
Agricultural Uses and Pharming
Cloning found some of its earliest real-world traction in agriculture. The ability to make genetic copies of high-value animals, an elite dairy cow or a champion bull, is commercially attractive, and SCNT has become an established tool for producing transgenic livestock.22PubMed Central. Benefits and problems with cloning animals This often intersects with “pharming,” where animals are engineered to produce medically useful proteins in their milk. In one program, cloned transgenic cattle were created that expressed recombinant human albumin in their milk at concentrations ranging from 1 to 2 grams per liter up to more than 40 grams per liter.23PubMed. Production of recombinant albumin by a herd of cloned transgenic cattle Albumin is used in large quantities in clinical medicine, so a biological production system like this could supplement traditional manufacturing.
Gene cloning techniques feed directly into this work. Researchers first build the transgene construct using molecular cloning methods, verify it in bacterial cells, then introduce it into livestock cells that will serve as nucleus donors for SCNT. The two categories of cloning, molecular and organismal, converge in these applications.
Interspecies Cloning and Conservation
With roughly a quarter of all mammal species threatened with extinction according to the IUCN Red List, SCNT has been proposed as a conservation tool. If preserved cells from an endangered or recently extinct species exist, they could theoretically serve as nucleus donors. The catch is that for rare species, eggs from the same species are usually unavailable, so researchers must use eggs from a related domestic species instead. This interspecies SCNT (iSCNT) has produced live offspring when the two species involved are close relatives, but when the taxonomic distance widens, embryos typically stall at very early stages.24PubMed. The perspective of the incompatible of nucleus and mitochondria in interspecies somatic cell nuclear transfer for endangered species
The mitochondrial mismatch problem described earlier is a major culprit here. When the donor nucleus and the recipient egg come from distantly related species, their mitochondrial and nuclear genomes may not cooperate efficiently, stalling the energy production the developing embryo desperately needs. Finding a suitable surrogate mother adds another layer of difficulty, since the surrogate’s uterine environment must be compatible with the cloned embryo’s developmental signals.
For species that have been extinct for centuries or longer, even iSCNT is unlikely to work because intact cells are needed and DNA degrades over time. A newer approach combines ancient DNA sequencing with genome editing: researchers edit the genome of a living cell from a close relative to resemble the extinct species, then use that edited cell as the donor for SCNT.25Functional Ecology. Pathways to de‐extinction: how close can we get to resurrection of an extinct species? This hybrid strategy, sometimes called de-extinction, is being pursued for species like the woolly mammoth and the thylacine. It produces something closer to a genetic approximation than a true clone, since the edited genome will never be a perfect match for the original species, and the mitochondrial genome will still come from the egg donor.
Where the Techniques Stand Relative to Each Other
The cloning landscape has settled into a rough division of labor. Molecular gene cloning and its newer assembly variants are everyday tools used in virtually every molecular biology lab on the planet. iPSC reprogramming has largely taken over the therapeutic and research applications that were once envisioned for therapeutic cloning, because it is simpler, avoids embryo creation, and produces functionally equivalent cells. SCNT remains the only method capable of producing a whole cloned animal, keeping it relevant in livestock production, conservation biology, and basic research into reprogramming. And genome editing techniques like CRISPR are increasingly being layered onto all of these methods, letting researchers not just copy genetic material but rewrite it before cloning begins.
Each technique has continued to improve in parallel, but the efficiency gap between molecular cloning (which works reliably nearly every time) and whole-organism cloning (which still fails more often than it succeeds across most species) remains wide. The epigenetic barriers that make SCNT so difficult are the same ones that make it scientifically fascinating: they reveal how tightly cells guard their identity, and how much biological information lives not in the DNA sequence itself but in the chemical marks draped over it.